Global Isotretinoin Drugs Market 2023-2029

March 2023 | 72 pages | ID: G3909BBBCDFBEN
Gen Consulting Company

Abstracts

Isotretinoin is a medication used to treat severe acne that has not responded to other treatments. It is a type of retinoid, a form of vitamin A, that works by decreasing the production of sebum in the skin and reducing inflammation. Isotretinoin is available under various brand names, including Accutane, Claravis, and Absorica, and is typically prescribed by a dermatologist. In 2022, the global isotretinoin drugs market stood at USD 1,321.0 million. Recording a CAGR of 4.49% from 2023 to 2029, the worth is projected to reach ~USD 1,796.5 million by 2029, according to the latest market data.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global isotretinoin drugs market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the form, indication, distribution channel, and region. The global market for isotretinoin drugs can be segmented by form: capsule, injection. In 2022, the capsule segment made up the largest share of revenue generated by the isotretinoin drugs market. Isotretinoin drugs market is further segmented by indication: severe acne, squamous cell carcinoma, cutaneous T- cell lymphoma, neuroblastoma, harlequin ichthyosis, xeroderma pigmentosum, fibrodysplasia ossificans progressive (FOP), others. The severe acne segment was the largest contributor to the global isotretinoin drugs market in 2022. Based on distribution channel, the isotretinoin drugs market is segmented into: hospital pharmacies, retail pharmacies, online pharmacies. The hospital pharmacies segment is estimated to account for the largest share of the global isotretinoin drugs market. On the basis of region, the isotretinoin drugs market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global isotretinoin drugs market in 2022 and is anticipated to hold its share during the forecast period.

Market Segmentation
By form: capsule, injection
By indication: severe acne, squamous cell carcinoma, cutaneous T- cell lymphoma, neuroblastoma, harlequin ichthyosis, xeroderma pigmentosum, fibrodysplasia ossificans progressive (FOP), others
By distribution channel: hospital pharmacies, retail pharmacies, online pharmacies
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Douglas Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Ltd., F. Hoffmann-La Roche Ltd., Sun Pharmaceuticals Industries Limited, Viatris Inc., Chongqing Huapont Shengchem Pharm. Co., Ltd., Cipher Pharmaceuticals Inc., GlaxoSmithKline plc, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global isotretinoin drugs market.
To classify and forecast the global isotretinoin drugs market based on form, indication, distribution channel, region.
To identify drivers and challenges for the global isotretinoin drugs market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global isotretinoin drugs market.
To identify and analyze the profile of leading players operating in the global isotretinoin drugs market.

Why Choose This Report
Gain a reliable outlook of the global isotretinoin drugs market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY FORM

Capsule
Injection

PART 6. MARKET BREAKDOWN BY INDICATION

Severe acne
Squamous cell carcinoma
Cutaneous T- cell lymphoma
Neuroblastoma
Harlequin ichthyosis
Xeroderma pigmentosum
Fibrodysplasia ossificans progressive (FOP)
Others

PART 7. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL

Hospital pharmacies
Retail pharmacies
Online pharmacies

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Douglas Pharmaceuticals Limited
Teva Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories, Ltd.
F. Hoffmann-La Roche Ltd.
Sun Pharmaceuticals Industries Limited
Viatris Inc.
Chongqing Huapont Shengchem Pharm. Co., Ltd.
Cipher Pharmaceuticals Inc.
GlaxoSmithKline plc

DISCLAIMER